Health Condition 1: N946- Dysmenorrhea, unspecified
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: H/O Painful menstruation and pain few days prior to menstruation for atleast three consecutive cycle Age group of 15-49 year Patient having moderate to severe pain acc to MRC grading recommended by WHO Patient suffering from any type of menstrual pain premenstrual pain and average bleeding during periods periods that persisted for 3 months prior to the study will be included Patients with fibroids less than 3cm who had secondary dysmenorrhoea without menorrhagia Endometriosis Adenomyosis with regular periods and average bleeding during periods that persisted for 3 months prior to the study will be included
Exclusion criteria
Exclusion criteria: Congenital anomalies Patient on hormonal therapy Pelvic Inflammatory Disease Endometrial Hyperplasia Patients who are taking oral contraceptive pill IUCD suffered from chronic general illness pregnant women lactating women Uterine fibroids of size greater than 3cm with menorrhagia Patient having irregular periods Abnormal Uterine Bleeding Menstrual Pain associated with Menorrhagia and Metrorrhagia Ovarian Cyst greater than 6cm Known cases of systemic illness like cancer tuberculosis diabetes etc Known cases of cardiovascular hematologic hepatic gastrointestinal renal pulmonary endocrinologic neurologic disease Known cases of hypersensitivity or contraindication to drotaverine
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Reduction in scoring of VAS and MRS grading 80% reductionTimepoint: Baseline 1st 2nd and 3rd Menstrual Cycle | — |
Secondary
| Measure | Time frame |
|---|---|
| Reduction in associated systemic symptoms Nausea Vomiting Headache Fatigue DiarrhoeaTimepoint: Baseline and 3rd Menstrual Cycle | — |
Countries
India
Contacts
Shri Dhanwantry Ayurvedic College and Hospital